Keep Calm and Sell Drugs: Your New Daily Affirmation?

To be sure, anything borrowing from the well-known "Keep Calm" genre should not be construed as advice. The doctor is definitely not in.

40 Different Ways to Reshape Healthcare

Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.

Is a Crisis Brewing for Watson Health?

In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.

Another Pharmageddon? The Looming Threat to 2017 Ad Budgets

Despite budgets bouncing back from a decrease in 2015, big threats have appeared that may temper future plans, Iskowitz writes.

Pharma/Payer Collaboration: A Kumbaya Moment or a Passing Trend?

The idea is that each gets some of what it needs. Payers gain some control over cost, and pharma may get to stay on formulary.

MM&M's new logo reflects the evolving industry

This month we will debut a restyled MM&M logo on our website, in a mobile-friendly, redesigned email newsletter, and on the cover of our magazine.

The New Reality for Pharma Marketers is Drug Pricing

My hope is that all of us do a better job of focusing on value.

How We Picked the Health Influencer 50

Each of this year's Influencers wields significant influence at a major health-related organization and boasts high-profile accomplishments, oftentimes ahead of the aforementioned pain-of- change curve.

MM&M's First 50 Years: A Look at What's Changed for Pharma, and What Hasn't

Some innovations are still emerging, while others seem more elusive than ever. You'll find many moments whose impact resonates through time.

Five-Figure Salaries. Big Hair. Pharma, 1987

When the Career and Salary Survey made its debut, in 1987, Eli Lilly's Prozac led the list of mass-market drug launches and AIDS therapy had taken a big step forward with the approval of GlaxoSmithKline's AZT, a year earlier.